Ciloxan Ophthalmic Solution

Dosaggio del prodotto: 5 ml
Confezione (n.)Per flaconiPrezzoAcquista
4€10.62€42.49 (0%)🛒 Aggiungi al carrello
5€9.69€53.12 €48.44 (9%)🛒 Aggiungi al carrello
6
€8.92 Migliore per flaconi
€63.74 €53.54 (16%)🛒 Aggiungi al carrello
Sinonimi

Prodotti simili

Let’s be honest: when I first heard “Ciloxan Ophthalmic Solution,” I thought it was just another antibiotic drop, a me-too product you’d prescribe for a pink eye and move on. I was wrong. Dead wrong. After a decade in practice, including a particularly nasty case of a corneal ulcer in a 45-year-old diabetic who’d lost vision in his other eye to a similar infection, I’ve come to respect this drug. It’s not glamorous. It’s not a blockbuster. But when used correctly, it’s a surgical instrument in a bottle.

Ciloxan is the brand name for ciprofloxacin hydrochloride ophthalmic solution. It’s a fluoroquinolone antibiotic, specifically a 0.3% sterile solution, manufactured by Alcon (now part of Novartis). It’s approved by the FDA, EMA, and most major regulatory bodies for the treatment of bacterial keratitis (corneal ulcers) and bacterial conjunctivitis.

But here’s the thing: the monograph you’ll find in the PDR is sterile and dry. It tells you the dose, the mechanism, the side effects. It does not tell you the war stories. It does not tell you why you might choose Ciloxan over, say, moxifloxacin (Vigamox) or ofloxacin (Ocuflox). So let’s fix that.

Introduction: What is Ciloxan Ophthalmic Solution? Its Role in Modern Medicine

Ciloxan Ophthalmic Solution is a topical fluoroquinolone antibiotic. Its primary active ingredient is ciprofloxacin, a broad-spectrum bactericidal agent. It’s used to treat superficial ocular infections caused by susceptible bacteria, including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa.

Why is this important? Because Pseudomonas is the bogeyman of ophthalmology. A Pseudomonas corneal ulcer can perforate the eye within 24–48 hours. You don’t have time to wait for culture results. You need a drug that works. Ciloxan is one of the few topical antibiotics that reliably covers Pseudomonas, and it does so with a relatively low resistance rate compared to older drugs like gentamicin or tobramycin.

In my practice, I don’t use Ciloxan for simple conjunctivitis. That’s overkill. But for a patient with a contact lens-related corneal ulcer, especially if they’re a young, otherwise healthy adult, Ciloxan is my go-to. It’s the difference between saving the eye and a corneal transplant.

Key Components and Bioavailability

The solution is 0.3% ciprofloxacin. That’s 3 mg/mL. It’s formulated with benzalkonium chloride as a preservative, which is standard for multi-dose ophthalmic bottles. The pH is adjusted to around 4.5, which is important for solubility but also explains the infamous “stinging” sensation.

Now, let’s talk about bioavailability. Topical ciprofloxacin achieves high concentrations in the corneal stroma and aqueous humor after repeated dosing. Studies show that after a single drop, the concentration in the cornea can exceed the MIC90 (minimum inhibitory concentration) for most susceptible pathogens within 15 minutes. For severe infections like bacterial keratitis, the recommended dosing is aggressive: every 15 to 30 minutes for the first 6 hours, then every 30 to 60 minutes for the next 24 hours, then tapered.

This is not a “once a day” drug. This is a “set an alarm and wake up every hour” drug. I’ve had patients who gave up because it stung too much. I’ve had patients who stuck with it and kept their vision. The difference is education. You need to tell the patient: “This will sting. That means it’s working. Do not stop.”

Mechanism of Action: Scientific Substantiation

Ciprofloxacin works by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for bacterial DNA replication, transcription, and repair. By binding to these targets, ciprofloxacin prevents the supercoiling of bacterial DNA, leading to rapid bacterial death.

Think of it this way: bacteria have a “spool” for their DNA. Ciprofloxacin breaks the spool. The DNA gets tangled, the cell can’t divide, and it dies. It’s a bactericidal drug, meaning it kills the bacteria outright, rather than just stopping them from growing (bacteriostatic).

The key advantage over older fluoroquinolones (like norfloxacin) is the enhanced Gram-negative coverage, especially Pseudomonas. The key disadvantage compared to newer fluoroquinolones (like moxifloxacin) is the reduced Gram-positive coverage, particularly against Streptococcus pneumoniae and some Staphylococci. There was a study—I think it was in the Journal of Cataract and Refractive Surgery in the early 2000s—that showed moxifloxacin had better penetration into the anterior chamber than ciprofloxacin. But for corneal ulcers, where you need high stromal concentrations, Ciloxan still holds its own.

Indications for Use: What is Ciloxan Effective For?

Bacterial Conjunctivitis

Ciloxan is approved for the treatment of bacterial conjunctivitis caused by susceptible strains. However, I’d argue that in most healthy adults, simple conjunctivitis is viral and doesn’t need antibiotics. The risk of resistance outweighs the benefit. Use Ciloxan only if you have a clear clinical suspicion of bacterial infection, such as purulent discharge, lid edema, or a history of contact lens use.

Bacterial Keratitis (Corneal Ulcers)

This is where Ciloxan shines. It’s the first-line treatment for suspected bacterial keratitis, especially if Pseudomonas is a concern. The dosing is aggressive, as I mentioned. I’ve seen ulcers that looked like a cloudy white crater on the cornea resolve within 48 hours with Ciloxan. I’ve also seen failures, usually due to resistant Staphylococci or Streptococci. In those cases, you need to switch to fortified vancomycin or a fourth-generation fluoroquinolone.

Preoperative Prophylaxis

Some surgeons use Ciloxan as a preoperative prophylactic agent for cataract surgery or refractive surgery. I’m not a fan. The stinging can cause patient discomfort, and the risk of corneal toxicity with repeated dosing is real. I prefer moxifloxacin or gatifloxacin for prophylaxis.

Instructions for Use: Dosage and Course of Administration

For bacterial conjunctivitis:

  • Days 1 and 2: Instill 1–2 drops into the affected eye(s) every 2 hours while awake.
  • Days 3 through 7: Instill 1–2 drops every 4 hours while awake.

For bacterial keratitis:

  • Day 1: Instill 1–2 drops every 15–30 minutes for the first 6 hours, then every 30–60 minutes for the remainder of the day.
  • Day 2: Instill 1–2 drops every hour while awake.
  • Days 3 through 14: Instill 1–2 drops every 4 hours while awake.

The duration of treatment depends on the severity of the infection. I usually treat for 7–10 days for conjunctivitis and 14–21 days for keratitis.

Important: Do not touch the dropper tip to the eye or any surface. This is how you contaminate the bottle. I’ve seen patients who got reinfected because they used the same bottle after touching their infected eye.

Contraindications and Drug Interactions

Contraindications: Hypersensitivity to ciprofloxacin or any fluoroquinolone. Also, history of tendon rupture or tendinopathy with systemic fluoroquinolones is a contraindication for systemic use, but topical use is generally considered safe. However, I’d be cautious in patients with a history of severe systemic fluoroquinolone reactions.

Drug interactions: None significant for topical use. However, if you’re using other topical ophthalmic medications, space them at least 5 minutes apart to prevent washout.

Side effects: The most common is transient stinging or burning (about 10–15% of patients). Other side effects include blurred vision, photophobia, corneal deposits (white precipitates on the cornea, usually reversible), and rare allergic reactions.

Clinical Studies and Evidence Base

The clinical evidence for Ciloxan is robust. A landmark study by Leibowitz et al. (1991) compared ciprofloxacin to fortified tobramycin and cefazolin in the treatment of bacterial keratitis. The results showed that ciprofloxacin was as effective as the fortified regimen, with a success rate of over 90% for susceptible organisms.

Another study by the Ocular Ciprofloxacin Study Group (1993) evaluated the safety and efficacy of Ciloxan in over 600 patients with bacterial conjunctivitis. The clinical cure rate was 86% for ciprofloxacin compared to 70% for placebo.

However, there’s a darker side to the evidence. Resistance is rising. A 2018 study in Ophthalmology found that ciprofloxacin resistance in Staphylococcus aureus ocular isolates had increased from 10% to 30% over a decade. This is a problem. We are losing our first-line drugs.

Comparing Ciloxan with Similar Products

So, how does Ciloxan stack up against other fluoroquinolones?

  • Ciloxan (ciprofloxacin): Best for Pseudomonas. Stings. Good corneal penetration. Cheap.
  • Vigamox (moxifloxacin): Better Gram-positive coverage. Better anterior chamber penetration. Less stinging. More expensive.
  • Ocuflox (ofloxacin): Similar to ciprofloxacin but slightly less potent against Pseudomonas. Less sting.
  • Zymar (gatifloxacin): Similar to moxifloxacin. Good for prophylaxis.

My rule of thumb: If it’s a contact lens ulcer, use Ciloxan. If it’s a post-surgical infection, use Vigamox. If it’s a simple conjunctivitis, don’t use anything.

Frequently Asked Questions (FAQ)

For conjunctivitis, you should see improvement within 48 hours. For keratitis, you should see improvement within 24–48 hours. If not, culture the eye and consider switching antibiotics.

Can Ciloxan be combined with other medications?

Yes, but space them out. If you’re using a cycloplegic (like cyclopentolate) or a corticosteroid (like prednisolone), wait 5–10 minutes between drops.

Is Ciloxan safe during pregnancy?

The FDA category is C. Animal studies show some risk, but human data is limited. I avoid it in pregnancy unless the infection is severe.

Why does Ciloxan sting?

The low pH (4.5) and the preservative (benzalkonium chloride) cause the stinging. It’s transient and harmless.

Conclusion: Validity of Ciloxan Use in Clinical Practice

Ciloxan is a workhorse. It’s not perfect—the sting, the resistance, the limited Gram-positive coverage—but for Pseudomonas keratitis, it’s still the gold standard. I’ve used it in dozens of cases. I’ve seen it save eyes. I’ve also seen it fail, usually because of resistance or patient non-compliance due to the sting.

If you’re a patient: follow the dosing schedule exactly. Set alarms. Accept the sting. It’s temporary.

If you’re a clinician: know your resistance patterns. Don’t use it for trivial infections. Reserve it for the serious stuff.

And if you’re a researcher: we need better drugs. We need drugs that don’t sting, that have lower resistance, that penetrate the cornea better. Until then, Ciloxan is the best we’ve got for the worst infections.


Personal Anecdote

I remember a case from about five years ago. A 34-year-old woman, a PhD student, came in with a red, painful eye. She wore monthly contact lenses. She’d been sleeping in them for two weeks. Her cornea had a large infiltrate—about 4 mm—with an overlying epithelial defect. I scraped it, sent it for culture, and started her on Ciloxan every 30 minutes.

She called me at 2 AM the first night. “It burns so bad,” she said. “I can’t sleep.” I told her to keep going. She did. By day three, the infiltrate was shrinking. By day seven, the cornea was clear. The culture came back positive for Pseudomonas aeruginosa, sensitive to ciprofloxacin.

She finished her PhD. She still has 20/20 vision in that eye. She doesn’t wear contact lenses anymore.

That’s why I respect Ciloxan. It’s not a magic bullet. It’s a tool. And when you use it right, it works.